Prostate tumor microenvironment alters immune cells and prevents long-term survival in an orthotopic mouse model following flt3-ligand/CD40-ligand immunotherapy.
J. Immunother., 27(1):13-26 (2004 Jan-Feb)
Impact of the tumor microenvironment on host infiltrating cells and the efficacy of flt3-ligand combination immunotherapy evaluated in a treatment model of mouse prostate cancer.
Cancer Immunol. Immunother., Sep;52(9):535-45 (2003)
Orthotopic treatment model of prostate cancer and metastasis in the immunocompetent mouse: efficacy of flt3 ligand immunotherapy.
Int. J. Cancer., Dec;107(5):773-80 (2003)